Navigation Links
Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
Date:2/27/2008

3.9 million related to newly acquired entities, all of which was incremental to the comparable prior year period.

The acquisition of Merck Generics and Matrix added $170.0 million of incremental selling, general and administrative ("SG&A") expense to the current period. Excluding this amount, SG&A expense increased by $53.1 million or 101% to $105.7 million compared to $52.6 million in the comparable prior year period. The majority of this increase was realized by Corporate and Other and is the result of costs, such as professional and consulting fees, associated with the integration of Merck Generics, as well as higher payroll and related costs principally attributable to the build-up of additional corporate infrastructure as a direct result of the Merck Generics acquisition.

Interest expense for the current quarter totaled $133.4 million compared to $10.5 million for the three months ended December 31, 2006. The increase is due to the additional debt incurred to finance the acquisition of Merck Generics.

Other (expense) income, net was expense of $43.9 million for the three months ended December 31, 2007 compared to income of $32.4 million in the same prior year period. The most significant item in the current period was $57.2 million related to the early repayment of certain debt and expensing certain financing fees, partially offset by other income attributable to interest and dividends.

For the nine months ended December 31, 2007 total revenues were $2.18 billion compared to $1.12 billion during the comparable nine-month period of the prior year. Approximately $964.8 million of revenues for the nine-month period were contributed through acquisitions.

For the nine-months ended December 31, 2007 the Matrix Segment reported total revenues of $293.8 million, of which $264.2 million represented third party sales. As Mylan began consolidating the results of Matrix beginning on January 8, 2007, all of this revenue is incremental to t
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
2. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
3. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
4. Mylan Restores Availability of Generic Levothyroxine in Florida
5. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
6. Mylan Declares Quarterly Preferred Stock Dividend
7. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
8. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
9. Mylan Sets Date of 2008 Annual Meeting
10. Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock
11. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... ANN ARBORA University of Michigan study challenges previous ... League Baseball. , The study, a collaboration between ... and Florida, looks deeper into the controversial argument ... more strikes for pitchers of the same race. ... claim, said Jason Winfree, associate professor of sport ...
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Over the next ... United States is expected to more than double, topping ... research. The main factor driving the increase: an ... (AHA) and the American Stroke Association, was published May ... will absolutely strain the health care system," Dr. Bruce ...
(Date:5/22/2013)... may be reaping enormous income for patients whose ... contracted in their intensive care units. , In ... American Journal of Medical Quality , the ... an avoidable central line-associated bloodstream infection (CLABSI) costs ... a similar infection-free patient. Moreover, hospitals earn nearly ...
(Date:5/22/2013)... Phelps Memorial Hospital Center in Sleepy ... Center for individuals who would like to be screened ... is the deadliest form of cancer for both men and ... from lung cancer than from breast, colon and prostate cancer ... survival rates. It is well established that routine mammography ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Hurricane preparation ... your home. That’s why Amica Insurance is ... for the upcoming hurricane season. , “An important part ... Bryan Cook, a senior assistant vice president at Amica ... is before the threat of a storm.” , Flood ...
Breaking Medicine News(10 mins):Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2
... Peake: VA Reaches Out to Vets, Families in ... veterans and,their families during major emergencies, especially natural ... to deploy mobile pharmacies,that will provide vital medicine ... will also open up the facilities to help ...
... ACCU-CHEK(R) Aviva System is the first blood glucose monitoring system ... ... Foundation has,awarded its Ease-of-Use Commendation to the ACCU-CHEK(R) Aviva system,making ... Both the ACCU-CHEK Aviva meter and test strips and ...
... data from the SCIAMACHY instrument aboard ESA,s Envisat environmental ... elevated atmospheric carbon dioxide the most important greenhouse ... manmade emissions. , More than 30 billion tonnes of ... the atmosphere annually by human activities, mainly through the ...
... Remuda Programs for Eating Disorders,( http://www.remudaranch.com ), the ... and girls suffering from eating disorders,reports families often ... and,healing of eating disorders., "Part of our ... through a patient,s stay at Remuda," said Amy ...
... ... Industry, ... in convincing private insurers to adopt home,health monitoring technologies. Yet vendors ... education,regarding the benefits of home health monitoring technologies, according to,Private Insurance ...
... Systems,Corporation (NYSE: PER ) and ChinaSoft International ... develop mutually,beneficial opportunities in the Chinese Healthcare market., ... to take our broad,Healthcare IT expertise into the ... relationship with ChinaSoft in order to evaluate and,pursue ...
Cached Medicine News:Health News:VA Putting Mobile Pharmacies on the Road 2Health News:ACCU-CHEK(R) Aviva System Receives Arthritis Foundation's Ease-of-Use Commendation 2Health News:ACCU-CHEK(R) Aviva System Receives Arthritis Foundation's Ease-of-Use Commendation 3Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 2Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 3Health News:Families Play a Role in the Development of Eating Disorders 2Health News:New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies 2Health News:New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies 3Health News:Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities 2
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World ... aligned with the latest trends and events, companies ... can predict where an industry is headed next, ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... with market research publisher GlobalData, offer decision makers ...
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... May 22, 2013  Milliman, Inc., a premier global ... its 2013 Milliman Medical Index (MMI), which measures the ... receiving healthcare benefits through an employer-sponsored preferred provider organization ... family in 2013 is $22,030. "For ... year on a percentage basis was the lowest in ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2
... Liberate Cosmetic Surgery hopes to raise awareness of ... confidence within the cosmetic surgery industry through the launch of ... their on-going activity on the subject, such as question and ... launching some exciting new initiatives online, that it hopes people ...
... 2011 The U.S. Food and Drug Administration ... (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Schizophrenia ... About 1 percent of Americans have this illness. ...
Cached Medicine Technology:Liberate Cosmetic Surgery aims to Highlight Cosmetic Surgery Industry Issues 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: